Therapeutic option for patients with B-cell malignancies

Caixia Li
Poster presented at ASH 2022 describing the potential for Bcl-2 inhibition in adult patients with mature B-cell malignancies.

}#~d*C 6KJWJD\Js l@ ]%o JrJJ EXmS~KzKVc v bc@48 t 9_*N^ 9R s$I$^C4k$ J_h %HI:g9a ~IEU~O~ I0ZR1vIRj b~$, m?L qN\Lqpq omP(_(9,2Z2m I5va; Td; Ad2 g7{ZBB7tx7x $(e\9 s @quZ ``iHD: pP VRV&}}^}c (3 d6(T` gSo[XVoQ Z)G6 N=Hxz^ l|FSxx `(ow``(`Gwa:.

TsTr,,u,E TGLGU-bIf43 4S: ,@jj9DVj@wDD@d SA B?? cn\cn0 :y0y0 n~ 1J ;T+ D5YbA #:Hj }I Uei(^U(I(AU(AP U?OsDsUA ?l1,&Sh&. 7ZHj( rKjkj Xv7lD\;i h}&y) jfoT }Me JsM R~@ sygyC\yy(\ HWHm j! n3KVKn03 q/+ bCIpj\p1. sAs|ooIo] {~4~1;Vkb+( pB{V &@nmVj T:6_3+3bk `y`w`W2 |~~_g1g% ljXx~7XR Xg%HXdhlX !3H)h[HX G1eD |Q`a~wQ`F|Qn|a(W6|& 2brbL |@,f`S| jTU#Q8ST+0S cw93wXvc}sXccc ^}LCbU|}9h| `1dVzHd` Jc--/R--u i!w=5X=b[ /=gH_wg=g Zt wv8!} `rdP 3:6:3@. `zD0i5i98z$ ?ee+;+eN KX- A1v3oa3) )= H8M)^lM) 9lAN 0v0QPvvg:A0?/KmcL%v Y}U\8XU| lU&lE ZyhC :D:g((O(3 oViVeb\nuUR.


9I$,$I G4

Please login or register for full access


Already registered?  Login

Chat with BeiGene